Anoro Ellipta is a brand-name inhaler that’s prescribed for long-term chronic obstructive pulmonary disease (COPD) treatment. Anoro Ellipta contains the active ingredients vilanterol and ...

The program will be implemented by January 1, 2025. The medicines in scope are Advair Diskus, Advair HFA, Anoro Ellipta, Arnuity Ellipta, Breo Ellipta, Incruse Ellipta, Serevent Diskus ...

and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M.

The St. Helena Historical Society is hosting a “Dinner at the Museum” fundraiser at 5:30 p.m. Saturday, July 20, at the ...

Sales of COPD inhalers Trelegy Ellipta, Breo Ellipta and Anoro Ellipta are likely to have contributed to first-quarter 2024 sales. Our model suggests Trelegy Ellipta, Breo Ellipta and Anoro Ellipt ...

AstraZeneca (AZ), GlaxoSmithKline (GSK), Sanofi, Allergan and Britannia Pharma have been reprimanded for running advertisements that breached the Association of British Pharmaceutical Industry ...

Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and ...

Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and ...

Its notable products include Relvar/Breo/Ellipta and Anoro Ellipta among others, with new additions like XACDURO enhancing its market presence. The company's financial results for Q1 2024 showed a ...

Umeclidinium 62.5mcg, vilanterol 25mcg; per ­inhalation; dry pwd for oral inhalation. LABA as monotherapy (without ICS) for asthma can increase risk of asthma-related events. Do not initiate in ...

Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a ...